Log has written
TUESDAY, FEBRUARY 14, 2012

Bangalore: France-based Smartesting, which develops software test automation solutions, today announced setting up of its India operations here targeting a turnover of €2 million by 2010.

“Smartesting India, a wholly-owned subsidiary of the French firm, will aim at having a systematic approach to large IT, BPO companies like Infosys, Tatas, Wipro for adopting the solution for optimising its test centres,” Smartesting India MD Michel Guez said.

“The company will also pursue and intensify action carried out over the past year with local partner Qualitree in targeting customers here,” he said.

The new subsidiary also plans to build an integrated and dedicated software testing team in coordination with Qualitree.

“India is the gateway to the US market. We hope to access US clients through Indian IT service companies,” he said.

“We are not looking at the Indian market for product development or using Indian engineers for R&D, but rather for sale of the product,” he added.

The global software testing market is expected to touch $13 billion in 2010, of which 45% will be outsourced. Of the outsourced work, 70% is expected to come to India,” he said.

The current testing market in India is estimated at $700 million.

Tags - Find More Articles On:
READ MORE ARTICLES BY:
blog comments powered by Disqus
State Bank’s profit, bad loans rise
The lender may have beaten expectations with a 15.4% rise in profits, but its NPAs are at a six-year...
Lanco to exit wind energy business
Lanco’s decision comes at a time when the company is laden with a debt burden of Rs 29,665.7 crore
DGCA orders removal of Jet’s chief of flight safety
The regulator took the action against Jet Airways for allowing a trainee pilot to land a packed flight...
Govt set to gain ‘back-door’ access to corporate email
The government is just a step away from gaining access to RIM’s widely used BlackBerry Messenger...
Seth Berkley | Quality is key in having healthy vaccine market
Seth Berkley of GAVI Alliance spoke to Mint about the vaccine market and other initiatives by the organization